C
COV
CLEO DIAGNOSTICS
0.630
-0.025-3.82%Closed13:52 05/22 AEST
OPEN/PREV CLOSE0.660/0.655
TODAY RANGE0.630-0.665
VOL146.28K
MARKET CAP86.22M
52 WEEK RANGE0.310-0.900
AVG VOL (3M)223.10K
% TURNOVER0.11%
TURNOVER94.31K
P/E (TTM)-21.1409
% RANGE5.34%
EPS(TTM)-0.0298
P/E(FORWARD)--
P/B9.77
BVPS0.065
DIVIDEND--
P/S68.48
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP52.49M
SHARES OUTSTANDING136.86M
NEXT EARNINGS--
FREE FLOAT83.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·04/29 00:00
CLEO DIAGNOSTICS LTD Prelim Q3
ASX·04/28 00:00
CLEO Commences Kit Manufacturing Ahead of FDA Submission
ASX·03/30 22:06
Sample Collection Completion for Pivotal US Clinical Trial
ASX·03/22 21:31
CLEO Optimises Biomarker Panel Ahead of FDA Submission
ASX·02/25 05:25
Appendix 4D and Half Yearly Accounts
ASX·02/17 22:46
CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
ASX·01/28 21:27
Quarterly activities and cashflow report
ASX·01/05 04:27
Ceasing to be a substantial holder
ASX·12/29/2025 00:25
Chairman's End of Year Letter to Shareholders
ASX·12/29/2025 00:17
Cleansing Notice
ASX·12/29/2025 00:13
Notification regarding unquoted securities - COV
ASX·12/29/2025 00:05
Application for quotation of securities - COV
ASX·12/17/2025 22:55
Proposed issue of securities - COV
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others